Subscribe to RSS
DOI: 10.1055/s-0045-1805493
Endoscopic Ultrasound (EUS)-Guided Gallbladder Drainage vs EUS-Guided Bile Duct Drainage After Failed ERCP for Malignant Biliary Obstruction: An International Multicenter Study
Authors
Aims Endoscopic ultrasound (EUS)–guided gallbladder (GB) drainage and EUS-guided bile duct (BD) drainage with lumen-apposing metal stents are alternative approaches to endoscopic retrograde cholangiopancreatography (ERCP). We compared EUS-GB and EUS-BD as second line therapies in the setting of failed ERCP for malignant biliary obstruction (MBO) [1] [2] [3].
Methods This was an international multicenter retrospective observational study at 28 tertiary-care centers through August 2024. Consecutive patients with MBO who underwent EUS-GB or EUS-BD as second line therapy with LAMS placement were included. Outcomes were compared using propensity score matching. Cohorts were compared using Chi-square, Mann-Whitney tests, and logistic regression.
Results Five hundred and twenty-nine patients (254 males; average age 73±12 years) underwent EUS guided drainage where 136 patients underwent EUS GB drainage, and 393 patients underwent EUS BD drainage. Most patients developed MBO from pancreatic cancer (79%). AXIOS stents were used in most cases (91%) compared to SPAXUS (9%). Overall, technical success was reported in 96% of cases and clinical success in 87% of cases. After 1-to-1 propensity score matching, 224 patients were selected (112 per group). EUS-GB showed higher technical success compared to EUS-BD (97% vs 92%, P=0.045). However, EUS-GB showed lower clinical success compared to EUS-BD (74% vs 86%, P=0.030). No statistical differences were reported in adverse events for EUS-GB and EUS-BD including bleeding (6% vs 3%, P=0.196), perforation (0% vs 2%, P=0.155), stent occlusion (5% vs 4%, P=0.528), stent migration (2% vs 1%, P=0.561), and acute pancreatitis (2% vs 0%, P=0.155), respectively. Stent type was not associated with technical success (AXIOS 94% vs SPAXUS 94%, P=0.983) or clinical success (AXIOS 78% vs SPAXUS 88%, P=0.188). On univariate analysis, EUS-BD was not a significant predictor of technical success (P=0.059) but had higher odds of clinical success compared to EUS-GD (OR=2.10, 95% CL 1.07-4.13, P=0.032). univariate analysis.
Conclusions In patients with MBO, EUS-GB and EUS-BD are reasonable therapeutic alternatives in the setting of failed ERCP. However, EUS-BD may offer higher clinical success when compared to EUS-GB.
Publication History
Article published online:
27 March 2025
© 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Mangiavillano B, Moon JH, Facciorusso A, Di Matteo F, Paduano D, Bulajic M, Ofosu A, Auriemma F, Lamonaca L, Yoo HW, Rea R, Massidda M, Repici A.. EUS-guided biliary drainage with a novel electrocautery-enhanced lumen apposing metal stent as first approach for distal malignant biliary obstruction: a prospective study. Endosc Int Open 2022; 10 (07): E998-E1003 PMID: 35845026; PMCID: PMC9286767.
- 2 Paduano D, Facciorusso A, De Marco A, Ofosu A, Auriemma F, Calabrese F, Tarantino I, Franchellucci G, Lisotti A, Fusaroli P, Repici A, Mangiavillano B.. Endoscopic Ultrasound Guided Biliary Drainage in Malignant Distal Biliary Obstruction. Cancers (Basel) 2023; 15 (02): 490 PMID: 36672438; PMCID: PMC9856645.
- 3 Facciorusso A, Mangiavillano B, Paduano D, Binda C, Crinò SF, Gkolfakis P, Ramai D, Fugazza A, Tarantino I, Lisotti A, Fusaroli P, Fabbri C, Anderloni A.. Methods for Drainage of Distal Malignant Biliary Obstruction after ERCP Failure: A Systematic Review and Network Meta-Analysis. Cancers (Basel) 2022; 14 (13): 3291 PMID: 35805062; PMCID: PMC9266204.